DOI: 10.1055/s-00034925

Hämostaseologie

LinksClose Window

References


Global dosing hold in fitusiran trials initiated by Sanofi Genzyme to investigate new adverse events.
A joint statement of the World Federation of Hemophilia (WFH), European Haemophilia Consortium (EHC) and National Hemophilia Foundation (NHF). Published 2020. Accessed November 2020 at:
https://news.wfh.org/global-dosing-hold-in-fitusiran-trials-initiated-by-sanofi-genzyme-to-investigate-new-adverse-events/

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.